Lund Elmer Sandager is recognised for guiding clients through complex EU and Danish tender processes, advising both contracting authorities and bidders. The team prepares and completes intricate public procurements across all procedures and assists businesses in submitting compliant bids and challenging unfair decisions. With notable strength in life sciences, medtech and healthtech, the practice is highly regarded in regulated sectors. Co-head Thomas Rhyl is a leading EU and competition authority, alongside procurement specialist Sebastian Asbjørn Pedersen.
Legal 500 Editorial commentary
Key clients
- Ferring Pharmaceuticals Alcon Siemens Medical Smith & Nephew Smith & Nephew UK MAN Truck & Bus Boligtextilbranchens Indkøbsservice (Botex) PreMed A/S SVITZER Novartis Pharma Fynbus TårnbyForsyning A/S and affiliates Remondis A/S Forstas A/S Toyota Danmark A/S Midttrafik Sydtrafik Port of Hirtshals
Work highlights
Representing Novartis Pharma and Ferring Pharmaceuticals in Europe-wide litigation against parallel importers, securing CJEU judgments on the Falsified Medicines Directive and pursuing follow-on damages claims across five jurisdictions.
Representing Omni Bridgeway and 201 institutional investors in a damages claim, seeking over €2.6 billion from Danske Bank for alleged Market Abuse Regulation violations, following a related US plea deal resulting in a $2.1 billion fine, with trial scheduled for 2027.
Representing Botex (Boligtextilbranchens Indkøbsservice) in overturning a Danish Competition Council decision alleging hard-core advertising restrictions, with the Competition Appeals Tribunal annulling the ruling for flawed analysis and misapplication of EU guidelines; a subsequent similar decision is now under appeal with significant regulatory implications.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Practice head
Thomas Ryhl; Sebastian Asbjørn Pedersen